7-50058101-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_007009.3(ZPBP):āc.375T>Cā(p.Leu125=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0365 in 1,613,794 control chromosomes in the GnomAD database, including 1,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.031 ( 89 hom., cov: 32)
Exomes š: 0.037 ( 1125 hom. )
Consequence
ZPBP
NM_007009.3 synonymous
NM_007009.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.268
Genes affected
ZPBP (HGNC:15662): (zona pellucida binding protein) ZPBP is one of several proteins that are thought to participate in secondary binding between acrosome-reacted sperm and the egg-specific extracellular matrix, the zona pellucida (McLeskey et al., 1998 [PubMed 9378618]).[supplied by OMIM, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 7-50058101-A-G is Benign according to our data. Variant chr7-50058101-A-G is described in ClinVar as [Benign]. Clinvar id is 3037675.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.268 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.031 (4727/152316) while in subpopulation NFE AF= 0.045 (3060/68028). AF 95% confidence interval is 0.0437. There are 89 homozygotes in gnomad4. There are 2212 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 89 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZPBP | NM_007009.3 | c.375T>C | p.Leu125= | synonymous_variant | 4/8 | ENST00000046087.7 | NP_008940.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZPBP | ENST00000046087.7 | c.375T>C | p.Leu125= | synonymous_variant | 4/8 | 1 | NM_007009.3 | ENSP00000046087 | P4 | |
ZPBP | ENST00000419417.5 | c.372T>C | p.Leu124= | synonymous_variant | 4/8 | 1 | ENSP00000402071 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0311 AC: 4726AN: 152198Hom.: 89 Cov.: 32
GnomAD3 genomes
AF:
AC:
4726
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0311 AC: 7817AN: 251210Hom.: 163 AF XY: 0.0315 AC XY: 4278AN XY: 135768
GnomAD3 exomes
AF:
AC:
7817
AN:
251210
Hom.:
AF XY:
AC XY:
4278
AN XY:
135768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0370 AC: 54116AN: 1461478Hom.: 1125 Cov.: 32 AF XY: 0.0368 AC XY: 26741AN XY: 727044
GnomAD4 exome
AF:
AC:
54116
AN:
1461478
Hom.:
Cov.:
32
AF XY:
AC XY:
26741
AN XY:
727044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0310 AC: 4727AN: 152316Hom.: 89 Cov.: 32 AF XY: 0.0297 AC XY: 2212AN XY: 74480
GnomAD4 genome
AF:
AC:
4727
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
2212
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ZPBP-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at